← Back to Patent Explorer
US4456604A Expired / Lapsed US ⏱️ 0.0 years remaining

1-(3-Halo-2-pyridinyl) piperazine

Assignee: Merck and Co Inc
•
Filing: 1982-07-12
•
Granted: 1984-06-26
•
Expires: 2002-07-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 1-(3-Halo-2-pyridinyl)piperazine and its acid addition salts are selective alpha 2-adrenergic receptor antagonists and thereby useful as antidepressant agents and for treating sedation caused by antihypertensive therapy.

Inventors

  • 👤 Walfred S. Saari

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 21:55
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/60; C07D213/72; C07D213/74; C07D213/89

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 9 words
The compound 1-(3-fluoro-2-pyridinyl)piperazine or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 9 words
The compound 1-(3-fluoro-2-pyridinyl)piperazine or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 21 words
An antidepressant pharmaceutical formulation comprising a pharmaceutical carrier and an effective antidepressant amount of 1-(3-fluoro-2-pyridinyl)piperazine or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim 21 words
An antidepressant pharmaceutical formulation comprising a pharmaceutical carrier and an effective antidepressant amount of 1-(3-fluoro-2-pyridinyl)piperazine or a pharmaceutically acceptable salt thereof.
Claim 5
Independent Claim 29 words
A method of treating depression comprising the administration to a patient in need of such treatment of an effective antidepressant amount of 1-(3-fluoro-2-pyridinyl)piperazine or a pharmaceutically acceptable salt thereof.
Claim 6
Independent Claim 29 words
A method of treating depression comprising the administration to a patient in need of such treatment of an effective antidepressant amount of 1-(3-fluoro-2-pyridinyl)piperazine or a pharmaceutically acceptable salt thereof.

References Cited (Backward Citations)

US3177219A Cited
US2606906A Cited
US2663706A Cited
US2958694A Cited
US3773951A Cited
US4081542A Cited
US4082844A Cited
US4078063A Cited
US4310521A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-06-26 1987-12-26 1988-06-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-06-26 1991-12-26 1992-06-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-06-26 1995-12-26 1996-06-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag